CHARLESTON, S.C.--(BUSINESS WIRE)--Plasma Technologies LLC (PlasmaTech), a plasma biologics technology company, announced that its novel human plasma fractionation process has been shown to achieve a ...

The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...

very day, thousands of Indonesians donate blood and plasma, often unaware of the complex scientific and safety-driven processes that transform a single donation into life-saving therapies. As ...

ndonesia is set to host its first-ever plasma fractionation plant in Karawang, West Java, which is poised to become the largest such facility in Southeast Asia. This milestone marks a major step ...

IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) announced today that Grifols’ North Fractionation Facility in Clayton, N.C., was named the International Society for Pharmaceutical ...

ADMA Biologics receives FDA approval for a process enhancing plasma production yields by 20%, boosting growth and capacity for its products. ADMA Biologics, Inc. has announced the U.S. FDA approval of ...

The global plasma fractionation market can be segmented by product type, application, end-user, and geography. Some of the key players in the global plasma fractionation market include CSL Behring LLC ...

The plasma fractionation market is projected to reach US$ 40,731.98 million by 2028 from US$ 26,575.83 million in 2021; it is expected to grow at a CAGR of 6.3% during 2021-2028. According to the ...

Rwanda is expected to start exporting blood plasma for fractionation later this year, once the remaining technical and regulatory requirements are completed, according to Dr Thomas Muyombo, Blood ...

(MENAFN- GlobeNewsWire - Nasdaq) The global plasma fractionation market size is calculated at USD 37.87 billion in 2025 and is expected to reach around USD 72.86 billion by 2034, growing at a CAGR of ...